Charles River Laboratories traded at $218.83 this Friday July 1st, increasing $4.86 or 2.27 percent since the previous trading session. Looking back, over the last four weeks, Charles River Laboratories gained 10.77 percent. Over the last 12 months, its price fell by 41.52 percent. Looking ahead, we forecast Charles River Laboratories to be priced at 212.90 by the end of this quarter and at 196.06 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
218.83
Daily Change
2.27%
Yearly
-41.52%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 119.21 0.44 0.37% -19.90%
AmerisourceBergen 143.14 1.66 1.17% 22.74%
Align Technology 247.34 10.67 4.51% -60.37%
Elevance Health Inc 485.98 3.40 0.70% 25.51%
Bio-Rad Laboratories 502.34 7.34 1.48% -24.66%
Bruker 63.54 0.78 1.24% -18.08%
Cardinal Health 53.10 0.83 1.59% -8.26%
Cigna 268.03 4.51 1.71% 12.60%
Charles River Laboratories 218.83 4.86 2.27% -41.52%
Catalent 107.02 -0.27 -0.25% -3.69%
CVS Health 93.94 1.28 1.38% 13.96%
Quest Diagnostics 136.68 3.70 2.78% 2.52%
Danaher 258.05 4.53 1.79% -5.83%
Galapagos 53.06 -1.04 -1.92% -8.30%
Hologic 70.14 0.84 1.21% 3.59%
Humana 478.96 10.89 2.33% 6.02%
Illumina 191.04 6.68 3.62% -59.76%
Incyte Corp 77.67 1.70 2.24% -7.07%
IQVIA Holdings Inc 215.05 -1.94 -0.89% -13.69%
Laboratory Of America 240.94 6.58 2.81% -13.32%
Lonza Group 524.80 5.60 1.08% -19.93%
McKesson 329.53 3.32 1.02% 71.11%
Allscripts Healthcare Solutions 15.16 0.33 2.23% -17.52%
Merck 165.40 -0.30 -0.18% 1.26%
Mettler Toledo International 1,161.85 13.08 1.14% -17.08%
Novartis 81.65 1.32 1.64% -3.02%
Pfizer 52.31 -0.12 -0.23% 31.66%
PerkinElmer 144.07 1.85 1.30% -7.39%
Thermo Fisher Scientific 548.27 4.99 0.92% 6.81%
UnitedHealth 517.40 3.77 0.73% 26.39%
United Therapeutics 238.00 2.36 1.00% 29.12%
Waters 336.89 5.91 1.79% -5.23%
Walgreens Boots Alliance 38.56 0.66 1.74% -19.95%
West Pharmaceutical Services 307.74 5.37 1.78% -15.86%
Intrexon 1.41 0.07 5.22% -78.04%
Dentsply International 36.20 0.47 1.32% -43.34%

Indexes Price Day Year
US400 2296 26.97 1.19% -15.27%

Charles River Laboratories
Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.